Neuroone Medical Technologies (NMTC) Operating Expenses (2010 - 2026)

Neuroone Medical Technologies' Operating Expenses history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• Quarterly Operating Expenses fell 1.84% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (down 2.65% YoY) and the FY2025 annual result came in at $12.4 million, down 4.62% from the prior year.
• Operating Expenses was $3.4 million for Q1 2026 at Neuroone Medical Technologies, up from $3.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $3.8 million in Q2 2023 and bottomed at $2.8 million in Q2 2022.
• A 5-year average of $3.2 million and a median of $3.3 million in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses soared 36.26% — and 2024, when it declined 18.06%.
• Neuroone Medical Technologies' Operating Expenses stood at $3.2 million in 2022, then rose by 13.31% to $3.7 million in 2023, then retreated by 12.06% to $3.2 million in 2024, then rose by 1.85% to $3.3 million in 2025, then climbed by 3.43% to $3.4 million in 2026.
• Business Quant data shows NMTC's Operating Expenses at $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $2.9 million in Q3 2025.